Weight-loss drug available in Korea
Mock-ups of injectors for Wegovy, a weight-loss drug developed by Denmark's Novo Nordisk, are on display during a ceremony to celebrate its launch in the Korean market at a hotel in Seoul, Tuesday. Wegovy's local distributor started receiving orders for the drug the same day. Its product supply price is set at 372,025 won ($273) per unit, but the estimated final retail price for consumers exceeds 800,000 won since it is not covered by Korea's national health insurance. Yonhap
Oct 15, 2024By Park Jae-hyuk